Publication | Closed Access
Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats
23
Citations
21
References
2009
Year
InflammationMedicineVascular PharmacologyPhysiologyVascular BiologyExperimental PharmacologyPodocyte InjuryPharmacologyNeuropeptides
| Year | Citations | |
|---|---|---|
Page 1
Page 1